ZA200308838B - Diagnosis marker. - Google Patents
Diagnosis marker. Download PDFInfo
- Publication number
- ZA200308838B ZA200308838B ZA200308838A ZA200308838A ZA200308838B ZA 200308838 B ZA200308838 B ZA 200308838B ZA 200308838 A ZA200308838 A ZA 200308838A ZA 200308838 A ZA200308838 A ZA 200308838A ZA 200308838 B ZA200308838 B ZA 200308838B
- Authority
- ZA
- South Africa
- Prior art keywords
- gas
- mammal
- monitoring
- monitoring agent
- cardiac output
- Prior art date
Links
- 239000003550 marker Substances 0.000 title description 6
- 238000003745 diagnosis Methods 0.000 title description 2
- 239000007789 gas Substances 0.000 claims description 74
- 238000012544 monitoring process Methods 0.000 claims description 31
- 238000000034 method Methods 0.000 claims description 28
- 230000000747 cardiac effect Effects 0.000 claims description 27
- 241000124008 Mammalia Species 0.000 claims description 24
- GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 claims description 23
- 239000003795 chemical substances by application Substances 0.000 claims description 16
- 239000002243 precursor Substances 0.000 claims description 14
- 239000001272 nitrous oxide Substances 0.000 claims description 12
- 229930195733 hydrocarbon Natural products 0.000 claims description 6
- 150000002430 hydrocarbons Chemical class 0.000 claims description 6
- 238000001990 intravenous administration Methods 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 206010002091 Anaesthesia Diseases 0.000 claims description 5
- 238000001949 anaesthesia Methods 0.000 claims description 5
- 230000037005 anaesthesia Effects 0.000 claims description 5
- 238000002405 diagnostic procedure Methods 0.000 claims description 5
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 claims description 4
- 239000004215 Carbon black (E152) Substances 0.000 claims description 4
- 238000002347 injection Methods 0.000 claims description 4
- 239000007924 injection Substances 0.000 claims description 4
- 210000005245 right atrium Anatomy 0.000 claims description 4
- DFEYYRMXOJXZRJ-UHFFFAOYSA-N sevoflurane Chemical compound FCOC(C(F)(F)F)C(F)(F)F DFEYYRMXOJXZRJ-UHFFFAOYSA-N 0.000 claims description 3
- 229960000909 sulfur hexafluoride Drugs 0.000 claims description 3
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 claims description 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims description 2
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 claims description 2
- 229910052786 argon Inorganic materials 0.000 claims description 2
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 claims description 2
- 229910052743 krypton Inorganic materials 0.000 claims description 2
- DNNSSWSSYDEUBZ-UHFFFAOYSA-N krypton atom Chemical compound [Kr] DNNSSWSSYDEUBZ-UHFFFAOYSA-N 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 229910052756 noble gas Inorganic materials 0.000 claims description 2
- 229960002078 sevoflurane Drugs 0.000 claims description 2
- SFZCNBIFKDRMGX-UHFFFAOYSA-N sulfur hexafluoride Chemical compound FS(F)(F)(F)(F)F SFZCNBIFKDRMGX-UHFFFAOYSA-N 0.000 claims description 2
- 229910052724 xenon Inorganic materials 0.000 claims description 2
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 claims description 2
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 238000001514 detection method Methods 0.000 description 5
- 241000700199 Cavia porcellus Species 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 230000029058 respiratory gaseous exchange Effects 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 238000010253 intravenous injection Methods 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- HUAUNKAZQWMVFY-UHFFFAOYSA-M sodium;oxocalcium;hydroxide Chemical compound [OH-].[Na+].[Ca]=O HUAUNKAZQWMVFY-UHFFFAOYSA-M 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 101100129922 Caenorhabditis elegans pig-1 gene Proteins 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 101100520057 Drosophila melanogaster Pig1 gene Proteins 0.000 description 1
- 208000010496 Heart Arrest Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010021137 Hypovolaemia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 229910018503 SF6 Inorganic materials 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 229910001882 dioxygen Inorganic materials 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 239000003983 inhalation anesthetic agent Substances 0.000 description 1
- 238000012806 monitoring device Methods 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 210000001147 pulmonary artery Anatomy 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 210000005241 right ventricle Anatomy 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001839 systemic circulation Effects 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pathology (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0200932A SE0200932D0 (sv) | 2002-03-27 | 2002-03-27 | Diagnosis marker |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200308838B true ZA200308838B (en) | 2004-07-15 |
Family
ID=20287404
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200308838A ZA200308838B (en) | 2002-03-27 | 2003-11-13 | Diagnosis marker. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20040241097A1 (xx) |
| EP (1) | EP1487331A1 (xx) |
| JP (1) | JP2005520622A (xx) |
| CN (1) | CN1511046A (xx) |
| AU (1) | AU2003214757A1 (xx) |
| CA (1) | CA2448805A1 (xx) |
| SE (1) | SE0200932D0 (xx) |
| WO (1) | WO2003079921A1 (xx) |
| ZA (1) | ZA200308838B (xx) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080275355A1 (en) * | 2007-05-04 | 2008-11-06 | Ekips Technologies, Inc. | Method For Diagnosing An Infectioin Condition |
| CN112472069B (zh) * | 2020-11-26 | 2022-09-06 | 山东明骏生态农业科技有限公司 | 一种动物呼吸测热法及装置 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5042501A (en) * | 1990-05-01 | 1991-08-27 | Battelle Memorial Institute | Apparatus and method for analysis of expired breath |
| US5645072A (en) * | 1995-09-28 | 1997-07-08 | Thrall; Karla D. | Real time chemical exposure and risk monitor |
| WO2000042908A1 (en) * | 1999-01-21 | 2000-07-27 | Metasensors, Inc. | Non-invasive cardiac output and pulmonary function monitoring using respired gas analysis techniques and physiological modeling |
| US6254546B1 (en) * | 1999-12-07 | 2001-07-03 | Instrumentarium Corporation | Method to determine ventilation-perfusion and ventilation-volume distributions of the lungs |
-
2002
- 2002-03-27 SE SE0200932A patent/SE0200932D0/xx unknown
-
2003
- 2003-03-27 AU AU2003214757A patent/AU2003214757A1/en not_active Abandoned
- 2003-03-27 JP JP2003577756A patent/JP2005520622A/ja active Pending
- 2003-03-27 EP EP03710586A patent/EP1487331A1/en not_active Withdrawn
- 2003-03-27 CN CNA038003236A patent/CN1511046A/zh active Pending
- 2003-03-27 WO PCT/SE2003/000510 patent/WO2003079921A1/en not_active Application Discontinuation
- 2003-03-27 CA CA002448805A patent/CA2448805A1/en not_active Abandoned
- 2003-03-27 US US10/478,958 patent/US20040241097A1/en not_active Abandoned
- 2003-11-13 ZA ZA200308838A patent/ZA200308838B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20040241097A1 (en) | 2004-12-02 |
| CA2448805A1 (en) | 2003-10-02 |
| JP2005520622A (ja) | 2005-07-14 |
| EP1487331A1 (en) | 2004-12-22 |
| SE0200932D0 (sv) | 2002-03-27 |
| AU2003214757A1 (en) | 2003-10-08 |
| WO2003079921A8 (en) | 2004-04-22 |
| CN1511046A (zh) | 2004-07-07 |
| WO2003079921A1 (en) | 2003-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8479731B2 (en) | Method and apparatus for indicating the absence of a pulmonary embolism in a patient | |
| US7104964B2 (en) | Non-invasive device and method for the diagnosis of pulmonary vascular occlusions | |
| US7066892B2 (en) | Non-invasive device and method for the diagnosis of pulmonary vascular occlusions | |
| Marshall et al. | The physiologic evaluation of the lung resection candidate | |
| US7070569B2 (en) | Non-invasive determination of conditions in the circulatory system of a subject | |
| US6200271B1 (en) | Bi-directional partial re-breathing method | |
| US6210342B1 (en) | Bi-directional partial re-breathing method | |
| Jubran et al. | Monitoring during mechanical ventilation | |
| AU2002324876A1 (en) | Non-invasive device and method for the diagnosis of pulmonary vascular occlusions | |
| Santos et al. | Practical uses of end-tidal carbon dioxide monitoring in the emergency department | |
| Williams et al. | Methods of studying lobar and segmental function of the lung in man | |
| WO1999053834A1 (en) | Determining cardiac output | |
| Paulus | Capnography. | |
| US20040241097A1 (en) | Diagnosis marker | |
| Breen | Carbon dioxide kinetics during anesthesia: pathophysiology and monitoring | |
| Gravenstein et al. | Capnography | |
| Hahn et al. | Continuous monitoring of irrigating fluid absorption during transurethral surgery | |
| EP1518560A1 (en) | Use of a gas for the manufacture of a diagnosing agent for diagnosing coronary perfusion | |
| Vanzeller et al. | Chronic respiratory failure–pathophysiology | |
| McCauley et al. | Noninvasive monitoring of the mechanically ventilated patient | |
| Vines | Respiratory Monitoring in Critical Care | |
| Gravenstein et al. | Civetta, Taylor, & Kirby's: Critical Care | |
| Badgwell | Respiratory gas monitoring in the pediatric patient | |
| Abubakar | 10-Capnography | |
| Macnaughton et al. | Physiological Assessment of Acute Lung Injury in the Intensive Care Unit |